"Canadian biotech cannot return to the good old days because its old business environment is gone. […] There are good times in the future for Canadian biotech, although they will look substantially different from the good old days. Canadian biotech must now chart a path forward to those good times." (quoted from the article)

Canadian biotech: the path forward | Biotechnology Focus
Capital markets, global healthcare systems and the pharmaceutical industry now live with the daily change and volatility that have always been part of biotech. There are good times in the future for Canadian biotech, although they will look substantially different from the good old days.

Tags:

Comments are closed.